The PARP inhibitor rucaparib blocks SARS-CoV-2 virus binding to cells and the immune reaction in models of COVID-19

Absztrakt
Leírás
Kulcsszavak
Forrás
British Journal Of Pharmacology. -[Epub ahead of print] (2024). -Br. J. Pharmacol. - 0007-1188